Related Experiment Video
Updated: Jan 5, 2026

Application of Robot-assisted Pancreaticobiliary Junction Resection in Benign Duodenal Tumors
Published on: December 20, 2024
Practical management of polyposis syndromes.
Roshani Patel1,2, Warren Hyer1
1Polyposis Registry, St Mark's Hospital, Harrow, UK.
Hereditary bowel tumor syndromes, including polyposis syndromes, account for 5%-10% of colorectal cancers. Early diagnosis and specialized management are crucial for patients and at-risk relatives.
Area of Science:
- Gastroenterology
- Genetics
- Oncology
Background:
- Hereditary bowel tumors often present as distinct syndromes requiring management of both intestinal and extra-intestinal manifestations.
- Polyposis syndromes, such as Familial Adenomatous Polyposis and MUTYH-associated polyposis, encompass a range of genetic conditions.
- These hereditary syndromes are responsible for 5%-10% of all colorectal cancers (CRC).
Purpose of the Study:
- To review the evolving landscape of diagnosis and management for hereditary polyposis syndromes.
- To highlight the importance of genetic advancements, endoscopic therapies, and registry data in guiding patient care.
- To emphasize the goals of polyposis management, including patient treatment and identification/screening of at-risk individuals.
Main Methods:
- Review of current scientific literature and advancements in genetic identification of causative genes.
- Analysis of sophisticated endoscopic therapy techniques for polyp management.
- Integration of data from polyposis registries to inform clinical management strategies.
- Discussion of diagnostic approaches, including genetic testing and clinical recognition, acknowledging potential syndrome overlaps.
Main Results:
- Diagnosis and management strategies for polyposis syndromes are continuously advancing.
- Polyposis registries provide valuable data for guiding clinical decisions in these rare conditions.
- Accurate diagnosis, whether genetic or clinical, is essential for effective management.
- Overlapping syndrome features can present diagnostic challenges.
Conclusions:
- Effective management of hereditary bowel tumors necessitates a comprehensive approach addressing both intestinal and extra-intestinal aspects.
- Referral to specialized genetics centers or polyposis registries is recommended for optimal diagnosis and management of patients and their families.
- Screening, genetic testing, and endoscopic surveillance are key components in managing at-risk individuals and preventing disease progression.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Chronic Pancreatitis II: Collaborative Care
Assessment:
Cystic Fibrosis: Management
Sinus disease and chronic...
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
